Our proposed molecular mechanism suggests that MH7A cell‐derived Lnc‐ENST00000602558 acts as a novel and important factor that improves the therapeutic effect of TG on RA by inhibiting IGF1 expression. The gene discussed is IGF1; the disease is rheumatoid arthritis.